3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Dermatologic
1
CNS
1
Conditions
Brain Neoplasms
34
Glioblastoma
8
Glioma
7
Meningeal Carcinomatosis
6
Epilepsy
5
Neuroblastoma
4
Neoplasms
4
Neoplasm Metastasis
4
Pituitary Neoplasms
3
Meningioma
3
Melanoma
3
Lung Neoplasms
3
Breast Neoplasms
3
Seizures
2
Retinoblastoma
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Paraganglioma
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroma, Acoustic
2
Neurofibromatosis 1
2
Medulloblastoma
2
Leukemia, Myeloid, Acute
2
Delirium
2
Central Nervous System Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Wilms Tumor
1
Stroke
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
CNS
×
Clear all
NCT05235737
2023-08-31
PIRG
Medical University of Silesia
Phase 4
Unknown
36 enrolled